Pharma News - Drug/Product Approvals News & Articles

121 FDA Drug Safety Communication: New information regarding QT prolongation with ondansetron (Zofran) Full Text FDA What's New: Drugs, February 27, 2013

122 FDA seeks input on minimizing disruptions to medical device supply chain during extreme weather events Full Text FDA Press Announcements, February 27, 2013

123 FDA Drug Safety Communication: Safety review update of cancer drug Revlimid (lenalidomide) and risk of developing new types of malignancies Full Text FDA What's New: Drugs, February 27, 2013

124 Actavis Generic Suboxone Receives FDA Approval Full Text Actavis, February 27, 2013

125 FDA issues draft guidance on drug development for Alzheimer's Full Text Formulary , February 26, 2013

126 FDA Warning: Driving May Be Impaired the Morning Following Sleeping Pill Use JAMA, February 25, 2013

127 Potential Role of UGT1A4 Promoter Snps in Anastrozole Pharmacogenomics Drug Metabolism and Disposition, February 25, 2013    Review Article

128 FDA seeks input on strategic plan to prevent drug shortages Full Text American Hospital Association News, February 22, 2013

129 FDA Drug Safety Communication: Planned return of CardioGen-82 to market with new Boxed Warning Full Text FDA What's New: Drugs, February 21, 2013

130 FDA Drug Safety Communication: Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses Full Text FDA What's New: Drugs, February 21, 2013

131 FDA Drug Safety Communication: Updated information about the risk of blood clots in women taking birth control pills containing drospirenone Full Text FDA What's New: Drugs, February 21, 2013

132 FDA Drug Safety Communication: Updated information on drug interactions between Victrelis (boceprevir) and certain boosted HIV protease inhibitor drugs Full Text FDA What's New: Drugs, February 21, 2013

133 FDA Drug Safety Communication: Update: Preliminary findings from ongoing investigations of CardioGen-82 Full Text FDA What's New: Drugs, February 21, 2013

134 FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab) Full Text FDA What's New: Drugs, February 21, 2013

135 Small Clinical Trials Feasible for New Limited-Population Approval Pathway Full Text Applied Clinical Trials, February 20, 2013

136 FDA approves first retinal implant for adults with rare genetic eye disease Full Text FDA Press Announcements, February 19, 2013

137 ViiV Healthcare announces FDA priority review designation for dolutegravir as a potential treatment for HIV infection Full Text GlaxoSmithKline, February 18, 2013

138 Teva Announces FDA Approval of Generic Adderall XR Full Text Teva Pharmaceutical Industries, February 18, 2013

139 Prostate cancer: Interventions aimed at improving morbidity, mortality Full Text American Pharmacists Association News, February 14, 2013

140 Multiple TKIs approved in recent months Full Text American Pharmacists Association News, February 14, 2013

1 U.S. FDA Approves INVOKANA (Canagliflozin) to Treat Adults with Type 2 Diabetes Janssen, April 1, 2013    Free full text

2 Daratumumab Granted Fast Track Designation from US Food and Drug Administration Genmab, April 3, 2013    Free full text

3 FDA approves treatment for postmenopausal women experiencing pain during intercourse Drug Topics, March 7, 2013    Free full text

4 FDA Releases Guidance on Non-Penicillin Beta-Lactam Drugs BioPharm International, April 18, 2013    Free full text

5 Merck Announces FDA Acceptance of New Drug Application for an Investigational Tablet Formulation of the Antifungal NOXAFIL (posaconazole) Merck, April 11, 2013    Free full text

6 CryoLife Receives FDA Clearance For Next Generation HeRO Device CryoLife, April 5, 2013    Free full text

7 Warner Chilcott Announces FDA Approval of New Oral Contraceptive Warner Chilcott, April 25, 2013    Free full text

8 Ospemifene: New treatment for postmenopausal women American Pharmacists Association News, April 5, 2013    Free full text

9 Bayer's Stivarga (regorafenib) Tablets Approved in Japan Onyx Pharmaceuticals, March 26, 2013    Free full text

10 Takeda and Millennium Announce Approval of ADCETRIS (Brentuximab Vedotin) in Switzerland Millennium Pharmaceuticals, April 8, 2013    Free full text

11 FDA approves Diclegis for pregnant women experiencing nausea and vomiting FDA Press Announcements, April 12, 2013    Free full text

12 FDA approves new multiple sclerosis treatment: Tecfidera FDA Press Announcements, April 1, 2013    Free full text

13 FDA approves once-monthly aripiprazole for schizophrenia Drug Topics, March 14, 2013    Free full text

14 Taro Receives FDA Approval For Topicort (desoximetasone) Topical Spray, 0.25% Taro Pharmaceuticals USA, April 15, 2013    Free full text

15 FDA Advisory Committee recommends approval of BREO ELLIPT for the treatment of COPD GlaxoSmithKline, April 19, 2013    Free full text

16 Gilead Submits New Drug Application to U.S. FDA for Sofosbuvir for the Treatment of Hepatitis C Gilead, April 9, 2013    Free full text

17 FDA approves first Botulism Antitoxin for use in neutralizing all seven known botulinum nerve toxin serotypes FDA Press Announcements, March 25, 2013    Free full text

18 FDA Approves New Drug Application (NDA) for Tevas Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) Tablets for the Prevention of Pregnancy Teva Pharmaceutical Industries, April 10, 2013    Free full text

19 FDA approves Invokana to treat type 2 diabetes FDA Press Announcements, April 1, 2013    Free full text

20 Sarepta Therapeutics Announces FDA Will Consider Accelerated Approval for Eteplirsen After Further Review of Data on Dystrophin and Clinical Outcomes Sarepta Therapeutics, April 19, 2013    Free full text